Connect with us

Hi, what are you looking for?


Gov’t approves emergency use of AstraZeneca COVID vaccine

THE LOCAL Food and Drug Administration (FDA) has approved the emergency use of AstraZeneca Plc’s coronavirus vaccine in the Philippines, the second approval after Pfizer, Inc.

Evidence and data show it is reasonable to believe that the vaccine might be effective against the coronavirus disease 2019 (COVID-19) virus, FDA Director General Rolando Enrique D. Domingo told an online news briefing on Thursday. The benefits outweigh potential risks, he added.

The vaccine had no safety concerns and its adverse effects were “transient and mostly mild to moderate, similar to common vaccine reactions,” he said.

AstraZeneca’s vaccine has an efficacy of 70% after the first dose and requires a second dose after four to 12 weeks, Mr. Domingo said.

In a statement, the British drug maker said the vaccine could be given to people 18 years old and above. 

It can be stored and handled at normal refrigerated conditions at 2 to 8 degrees Celsius for at least six months.

“This emergency use authorization (EUA) will give millions of Filipinos access to AstraZeneca’s effective, well-tolerated and simple-to-administer vaccine once supply becomes available,” AstraZeneca Philippines Country President Lotis Ramin said in the statement.

“We will continue to fulfill our commitment to provide broad and equitable access at no profit as we work with the Philippine government to pave the way for a return to normalcy and the country’s full economic recovery,” she added.

The National government, local government units (LGUs) and private sector signed an agreement to buy 17 million doses of Astrazeneca vaccines this month.

Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, China’s Sinovac Biotech Ltd. and India’s Bharat Biotech also have pending applications for emergency use in the Philippines. — Vann Marlo M. Villegas

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



The Bank of the Philippines Islands (BPI) secured back-to-back awards from a multitude of notable local and regional awarding entities throughout 2022. These recognitions...


A glittering night of celebration for the UK’s 140 finalists of the Business Champion Awards. Over 300 guests filled the East Wintergardens in London’s...


THE PHILIPPINE government should take time to study the transport modernization program and execute it properly rather than rush the whole process, according to...


Shinagawa Healthcare Solutions Corp. is preparing to open a diagnostic and preventive care center in Bonifacio Global City (BGC) next month, the company’s president...


The Philippine government is planning to launch a retail dollar bond offering next month, Finance Secretary Benjamin E. Diokno said. “We plan to launch...


Fisherfolk, farmers, children, and individuals residing in rural areas remained the poorest sectors in 2021, according to the Philippine Statistics Authority (PSA). Preliminary estimates...

You May Also Like


Browsing history makes referring to sites and pages you’ve visited in the past seamless. It’ll help you recall what page you checked out on...


The minute that any question pops into your head, you can simply ask Google. No longer do we have to pour over books and...


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.